2017_IGRT course book

Endpoints

Primary endpoint • Acute non-genitourinary grade 3 or greater toxicity (up to 3 months following treatment completion)

Secondary endpoints • Local disease control rate at 3 months • Control rate of presenting symptoms • Patient reported outcomes • Late toxicity • Time to local disease progression • Overall survival

• Proportion of fractions benefiting from adaptive planning • Appropriate identification and correction of fractions requiring adaptive planning

in partnership with